China Pharma (CPHI) News Today $0.19 0.00 (0.00%) (As of 11:06 AM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period China Pharma (NYSE:CPHI) Earns Hold Rating from Analysts at StockNews.comNovember 18 at 2:01 AM | americanbankingnews.comRoche Will Boost In-China Production for Local Market, CEO SaysOctober 9, 2024 | bloomberg.comSamsung Biologics eyes expansion amid US bio firms' decoupling from ChinaOctober 7, 2024 | msn.comChina's WuXi explores sale of pharma units as US restrictions loom, FT reportsOctober 3, 2024 | yahoo.comChina's WuXi explores sale of pharma operations as US restrictions loom, FT reportsOctober 3, 2024 | msn.comRegeneron, Sanofi Say Dupixent Approved In China To Treat Chronic Obstructive Pulmonary DiseaseSeptember 27, 2024 | markets.businessinsider.comChina Medical System: New Drug Application for Vitiligo Indication of Ruxolitinib Phosphate Cream Accepted in ChinaSeptember 25, 2024 | markets.businessinsider.comAcceleration in China+1 trend in Pharmaceuticals sector!August 31, 2024 | msn.comUS pharmaceutical companies ran drug trials with Chinese military for more than a decade, House committee revealsAugust 20, 2024 | msn.comChina Pharma Plans To Launch Dry Eye Disease Therapeutic Device In China - Quick FactsAugust 19, 2024 | markets.businessinsider.comChina Pharma Holdings, Inc. expects to launch its Dry Eye Disease Therapeutic Device in the first quarter of 2025August 19, 2024 | prnewswire.comPharmaceutical Excipients Market Size Expected to Reach USD 14.72 Bn by 2033August 7, 2024 | finance.yahoo.comQuantum pipeline unveiled in China could transform future of drug designingJuly 28, 2024 | msn.comDrug giants eye China for deals despite growing Sino-US tensionsJuly 23, 2024 | reuters.comChina's Philippines embassy demands answers for propaganda against COVID vaccineJuly 22, 2024 | reuters.comTianjin Pharma Announces Upcoming Investor BriefingMay 28, 2024 | nasdaq.comPhotocure : Asieris' NDA For Cevira Accepted By NMPA For Regulatory Review In ChinaMay 12, 2024 | markets.businessinsider.comChina Pharma Holding Inc CPHIMay 5, 2024 | morningstar.comChina Pharma Holding IncMarch 22, 2024 | morningstar.comChina Healthcare Stocks Rally on Hopes for Govt SupportMarch 14, 2024 | msn.comChina Healthcare Stocks Rally on Hopes for Govt SupportMarch 14, 2024 | msn.comRising Demand for Secure Packaging Solutions and Enhanced Aesthetic Appeal Propels Market to US$ 432.1M by 2034 | Future Market Insights, Inc.March 11, 2024 | tmcnet.comChina Pharma Holdings, Inc. (CPHI)March 6, 2024 | finance.yahoo.comChina Pharma Holding Stock (AMEX:CPHI), Insider Trading ActivityFebruary 27, 2024 | benzinga.comChina Pharma Holding Stock (AMEX:CPHI), Guidance and ForecastFebruary 27, 2024 | benzinga.comChina Pharma Holdings, Inc.: China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitFebruary 24, 2024 | finanznachrichten.deChina Pharma Holdings Inc. Announces 1-for-5 Reverse Stock SplitFebruary 23, 2024 | prnewswire.comChina Pharma Holdings Issues 15M Unregistered SharesFebruary 9, 2024 | markets.businessinsider.comChina Pharma Holdings Acquires Psoriasis Patent and Profit DealFebruary 9, 2024 | msn.comScoop: China panel plans biotech field hearingFebruary 6, 2024 | msn.comExclusive: China panel eyes biotech field hearingFebruary 6, 2024 | axios.comChina SXT Pharmaceuticals Inc (SXTC)January 23, 2024 | investing.comChina Pharma Holdings Inc.January 23, 2024 | wsj.comChina’s new cancer drug is approved in the US but will cost 30 times moreNovember 29, 2023 | msn.comChina Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceNovember 29, 2023 | finance.yahoo.comChina Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic DeviceNovember 29, 2023 | finance.yahoo.comAnother top executive is being investigated by China’s corruption watchdogNovember 21, 2023 | msn.comCASI PHARMACEUTICALS ANNOUNCES MARKET APPROVAL OF CNCT19 BY CHINA NMPANovember 8, 2023 | markets.businessinsider.comKexing Biopharm Attended CPHI Worldwide 2023November 7, 2023 | markets.businessinsider.comXinhua Silk Road: 54th Zhangshu National Traditional Chinese Materia Medica Trade Fair kicks off in E. China's JiangxiNovember 2, 2023 | markets.businessinsider.comIndia to witness the fastest growth rate in biologicals in next 5 years, CHPIOctober 25, 2023 | msn.comRecbio appeared at the 14th China (Taizhou) International Pharmaceutical FairOctober 24, 2023 | markets.businessinsider.comChina Grand Pharmaceutical and Healthcare Holdings Ltd (0512)September 22, 2023 | investing.comChina NT Pharma Group Co Ltd (1011)September 16, 2023 | investing.comWeek In Review: A Consortium Of China Drug Distributors Want To Acquire Poland's NeucaAugust 27, 2023 | msn.comIs China Pharma Holding (CPHI) A Hidden Gem or A Value Trap?August 24, 2023 | finance.yahoo.comSignal: Chinese economic slump hurts pharma firms invested in the regionAugust 23, 2023 | msn.comGov’t scientists got $325M in royalties from China, Russia, pharma firmsAugust 9, 2023 | msn.comChina Pharma: Candesartan Tablets Passes Generic-drug-consistency-evaluationAugust 9, 2023 | markets.businessinsider.comChina Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic DrugsAugust 9, 2023 | finance.yahoo.com Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Email Address This thing would have won 534 of the 550 trades placed in the last 11 years (Ad)Choosing what your next move will be is one of the most difficult choices investors are faced with today — especially in turbulent markets like these. But what if there was one technique that checked all these boxes? ✅ Allows traders of all stripes to target extra income week after week ✅ Won 534 of 550 trades according to our backtesting on 11-years worth of data ✅ Has maintained a shocking 97.1% through every market condition imaginable ✅ Sets up “Weekly Windfalls” every week so that it’s never trading opposite the broad market direction Well, we’re here to tell you, that strategy isn’t a pipe dream… It’s the same flagship strategy Chris Pulver just released an urgent briefing on! And your friends at Prosperity Pub have secured the video just for you. And with the very next trade dropping THIS WEEK you couldn't have better timing! While we cannot promise future returns or against losses, you have to… While we cannot promise future returns or against losses, you have to… Check out this training ses CPHI Media Mentions By Week CPHI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CPHI News Sentiment▼0.380.36▲Average Medical News Sentiment CPHI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CPHI Articles This Week▼10▲CPHI Articles Average Week Get China Pharma News Delivered to You Automatically Sign up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sensei Biotherapeutics News Today ImmunoPrecise Antibodies News Today NRx Pharmaceuticals News Today Aspira Women's Health News Today Turnstone Biologics News Today Avalo Therapeutics News Today Trinity Biotech News Today HCW Biologics News Today Indaptus Therapeutics News Today Eagle Pharmaceuticals News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:CPHI) was last updated on 11/20/2024 by MarketBeat.com Staff From Our PartnersAmazon's $150B Data Center Bet—What It Means for Uranium InvestorsAmazon is placing a massive bet on nuclear energy to power its $150 billion data center expansion. With dem...The Bull Report | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purpose...Priority Gold | SponsoredTesla Execs are Freaking OutIt’s so revolutionary that tech giants like Microsoft, Amazon, and NVIDIA are all lining up to get their hands...Angel Publishing | Sponsored[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you k...Crypto Swap Profits | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersTrump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax...Colonial Metals | SponsoredThis company will win the AI race Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally c...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding China Pharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share China Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.